Cargando…

Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review

OBJECTIVE: The objective of this study is to evaluate the efficacy of adjuvant interferon therapy for hepatitis B virus-related hepatocellular carcinoma (HCC) after different previous therapy. METHODS: An electronic search for articles about adjuvant treatment with IFN for patients with HCC publishe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shu, Lin, Qi, Lin, Wei, Hu, Weilei, Wang, Guosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899889/ https://www.ncbi.nlm.nih.gov/pubmed/27282382 http://dx.doi.org/10.1186/s12957-016-0912-7

Ejemplares similares

A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma
por: Jiang, Shaojie, et al.
Publicado: (2013)

Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma
por: Hu, Hao, et al.
Publicado: (2016)

Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma
por: Jiang, Jiang, et al.
Publicado: (2017)

Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma
por: Hsu, Ching-Sheng, et al.
Publicado: (2015)

Influence of Previous Interferon Therapy on Recurrence after Resection of Hepatitis C Virus‐related Hepatocellular Carcinoma
por: Kubo, Shoji, et al.
Publicado: (2001)

Adjuvant pegylated interferon therapy improves the survival outcomes in patients with hepatitis-related hepatocellular carcinoma after curative treatment: A meta-analysis
por: Wu, Jiansong, et al.
Publicado: (2018)

Prognostic Nomograms Combined Adjuvant Lenvatinib for Hepatitis B Virus–related Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection
por: Bai, Shilei, et al.
Publicado: (2022)

Postoperative adjuvant aspirin for patients with hepatitis B virus-related hepatocellular carcinoma and portal vein tumor thrombus: An open-label, randomized controlled trial
por: Lu, Chong-De, et al.
Publicado: (2023)

Interaction between hepatitis B virus infection and the efficacy of camrelizumab in combination with apatinib therapy in patients with hepatocellular carcinoma: a multicenter retrospective cohort study
por: Yuan, Guosheng, et al.
Publicado: (2021)

Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future
por: Koh, Sarene, et al.
Publicado: (2016)

Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma
por: Saito, Tomoko, et al.
Publicado: (2014)

Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma
por: Sun, Ruonan, et al.
Publicado: (2023)

Serum hepatitis B viral DNA in HBsAg-positive hepatocellular carcinoma treated with interferon or adriamycin.
por: Lin, H. J., et al.
Publicado: (1986)

Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma
por: Chen, Qi-Feng, et al.
Publicado: (2019)

H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection
por: Shen, Yu-Chuan, et al.
Publicado: (2022)

Effectiveness and safety of toripalimab, camrelizumab, and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients
por: Chen, Jinzhang, et al.
Publicado: (2020)

Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Karamitros, Timokratis, et al.
Publicado: (2018)

Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
por: Ke, Yang, et al.
Publicado: (2013)

Association of Adjuvant Antiviral Therapy with Risk of Cancer Progression and Deaths in Patients with Hepatitis-B-Virus-Related Hepatocellular Carcinoma following Curative Treatment: A Nationwide Cohort Study
por: Yeh, Yi-Chun, et al.
Publicado: (2014)

Hepatitis B Virus and Primary Hepatocellular Carcinoma
por: Sutton, R. N. P.
Publicado: (1982)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Rizzo, Giacomo Emanuele Maria, et al.
Publicado: (2022)

Liver regeneration accelerates hepatitis B virus‐related tumorigenesis of hepatocellular carcinoma
por: Teng, Chiao‐Fang, et al.
Publicado: (2018)

Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma
por: Yang, Suh Yoon, et al.
Publicado: (2014)

Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients
por: Hsu, Ching-Sheng, et al.
Publicado: (2013)

The Biological Function of Hepatitis B Virus X Protein in Hepatocellular Carcinoma
por: Xu, Qiaodong, et al.
Publicado: (2019)

Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
por: Li, Jiang, et al.
Publicado: (2023)

Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review
por: Raza, S A, et al.
Publicado: (2007)

Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma
por: Ji, Junfang, et al.
Publicado: (2013)

Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma
por: Petruzziello, Arnolfo
Publicado: (2018)

Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Luo, Xuan, et al.
Publicado: (2016)

Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
por: Yada, Masayoshi, et al.
Publicado: (2018)

Histological changes in patients who developed hepatocellular carcinoma after hepatitis C virus eradication by interferon-based therapy
por: Kawaguchi, Toshihiro, et al.
Publicado: (2019)

Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

Screening and Identification of Potential Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis
por: Zeng, Xian-Chang, et al.
Publicado: (2020)

Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
por: Lin, Chih-Lin, et al.
Publicado: (2023)

Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization
por: Tu, Xinyue, et al.
Publicado: (2023)

Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma
por: He, Xiu-Ting, et al.
Publicado: (2017)

Hepatitis B virus spliced variants are associated with an impaired response to interferon therapy
por: Chen, Jieliang, et al.
Publicado: (2015)

Hepatitis B Virus Genome Asymmetry in Hepatocellular Carcinoma
por: Shokrgozar, Zahra, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7k16ha11tjer97422nsscnldlr